Clinical Trial Update: SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating SGLT2 inhibitors in non-diabetic chronic kidney disease has completed, focusing on effects on vascular calcification and ane…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cardiovascular Calcification
• Chronic Kidney Disease

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Mansoura University | Conditions: Chronic Kidney Disease, Anemia | Phase 3 | Status: COMPLETED